Evaluation of efficacy and safety of Liv. 52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial

Research output: Contribution to journalArticle

Original languageUndefined
JournalMedicine
StatePublished - 2004

Cite this